<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9(3)</volume><submitter>Li G</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>To analyze the efficiency of low-intensity shock wave therapy (LI-ESWT) for patients with III B chronic pelvic pain syndrome (CPPS).&lt;h4>Methods&lt;/h4>The study included an uncontrolled population of 32 patients who had suffered with CPPS for ≥3 months. LI-ESWT was performed without anesthesia via a perineal approach. The operation was carried out in four weeks by administering 12,000 shock waves. Using the Visual Analog Scale (VAS) and NIH-developed Chronic Prostatitis Symptom Index (NIH-CPSI), subsequent tests were performed at 1, 2, 4, and 12 weeks after the first LI-ESWT session.&lt;h4>Results&lt;/h4>All patients who received the four week course as treatment responded actively on the pain VAS and the NIH-CPSI, and both were significantly improved (P&lt;0.05). Compared with the </pubmed_abstract><journal>Translational andrology and urology</journal><pagination>1323-1328</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7354340</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Low-intensity extracorporeal shock wave therapy for III B chronic pelvic pain syndrome.</pubmed_title><pmcid>PMC7354340</pmcid><pubmed_authors>Li G</pubmed_authors><pubmed_authors>Man L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Low-intensity extracorporeal shock wave therapy for III B chronic pelvic pain syndrome.</name><description>&lt;h4>Background&lt;/h4>To analyze the efficiency of low-intensity shock wave therapy (LI-ESWT) for patients with III B chronic pelvic pain syndrome (CPPS).&lt;h4>Methods&lt;/h4>The study included an uncontrolled population of 32 patients who had suffered with CPPS for ≥3 months. LI-ESWT was performed without anesthesia via a perineal approach. The operation was carried out in four weeks by administering 12,000 shock waves. Using the Visual Analog Scale (VAS) and NIH-developed Chronic Prostatitis Symptom Index (NIH-CPSI), subsequent tests were performed at 1, 2, 4, and 12 weeks after the first LI-ESWT session.&lt;h4>Results&lt;/h4>All patients who received the four week course as treatment responded actively on the pain VAS and the NIH-CPSI, and both were significantly improved (P&lt;0.05). Compared with the </description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Jun</publication><modification>2025-04-05T13:44:13.134Z</modification><creation>2025-04-05T13:44:13.134Z</creation></dates><accession>S-EPMC7354340</accession><cross_references><pubmed>32676416</pubmed><doi>10.21037/tau.2020.04.07</doi></cross_references></HashMap>